The slip
PARKINSON RECEIPTno. 11100
26 Oct 2026, 18:36 UTCdopamine neurons, braak
predictionWDR24 in dopamine neurons tracks Braak Lewy-body stage
registeredf1389f8ea7b63333
discovery-0.44 p=0.240 n=9
replication-0.74 p=0.024 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.44, p 0.240)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT20c04322c0139b2ee2ff3ea7…
follows 0bf3c1c9c21e…
Covered by the on-chain checkpoint of receipt 11102 (2026-10-26 18:39 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 11100: WDR24 in dopamine neurons, braak
- power
- full sample -0.57 (p 0.014, n 18), 95% CI -0.82 to -0.14. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.62 (p 0.0064, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.54 (p 0.021, n 18). not the mix.
- skeptic
- leave-one-out range -0.66 to -0.51, sign flips 0; without severely affected donors -0.57 (p 0.014, n 18). robust.
- cell type
- strongest in oligodendrocytes: -0.69 (p 0.0016, n 18) vs -0.57 in dopamine neurons. proposing oligodendrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for WDR24 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up WDR24 · oligodendrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.10 p 0.722 (needs p < 2.0e-4)